Press release
Recombinant Vaccines Market Forecast to Reach USD 30.6 Billion by 2030, Driven by Ongoing Technical Enhancements in Vaccine Production and Delivery
Recombinant Vaccines Market Size & Trends | Mordor Intelligence
Introduction
The recombinant vaccines market size stands at USD 18.3 billion in 2025 and is projected to reach USD 30.6 billion by 2030, reflecting an 11.1% CAGR over the forecast period, driven by steady demand across key disease areas and ongoing technical enhancements in vaccine production and delivery. This forecast reflects the increasing adoption of recombinant technology platforms, broader implementation of vaccine programs, and strong participation from both established and emerging market players in driving market expansion. The recombinant vaccines market size is supported by heightened global health initiatives, greater funding for rapid vaccine scalability, and evolving market dynamics that increase uptake and broader immunization coverage worldwide.
Report Overview:
https://www.mordorintelligence.com/industry-reports/recombinant-vaccines-market?utm_source=openpr
Key Trends
Strengthening Vaccine Mandates:
Increasing HPV immunization mandates and adult catch-up vaccination policies are supporting stable demand and reinforcing long-term market growth.
Boost in Manufacturing Readiness:
Expanded funding for rapid-scale production capabilities is improving manufacturing momentum and ensuring stronger preparedness for emerging infectious diseases.
Rise of Next-Generation Platforms:
Advanced technologies such as mRNA and VLP-based vaccines are gaining market traction, diversifying product pipelines, and accelerating innovation alongside traditional protein subunit vaccines.
Advances in Expression Systems:
Improvements in yeast and plant-based expression platforms are helping reduce production costs, enhance efficiency, and strengthen supply chain resilience across global immunization programs.
Market Segmentation
The recombinant vaccines market analysis includes several key segmentation categories that reveal how the market distributes demand and opportunities across different criteria
By Technology Type
Protein Subunit Vaccines
Virus-Like Particle (VLP) Vaccines
Viral Vector - Replicating
Viral Vector - Non-replicating
DNA Plasmid Vaccines
mRNA Vaccines
By Disease Indication
Human Papillomavirus (HPV)
Hepatitis B
Influenza
Shingles (Herpes Zoster)
Dengue
Malaria
Respiratory Syncytial Virus (RSV)
COVID-19
Oncology (Therapeutic Vaccines)
By Expression Platform
Yeast (Pichia, Saccharomyces)
Bacterial (E. coli)
Insect Cell (Baculovirus)
Mammalian Cell (CHO, HEK)
Plant-based
Cell-Free Synthetic
By End User
Pediatric
Adolescent & Adult
Geriatric
By Route of Administration
Intramuscular Injection
Subcutaneous Injection
Intradermal Injection
Oral
Others
By Geography
North America
Europe
Asia-Pacific
Middle East & Africa
South America
This segmentation insights into the recombinant vaccines market not only clarify demand distribution but also help stakeholders understand where future investment and development may be most impactful.
Key Players
The recombinant vaccines market share remains concentrated among a group of established vaccine manufacturers with a strong presence in both global and regional markets. Key players include major pharmaceutical companies that have extensive research and development infrastructure, broad product portfolios, and well-established manufacturing capabilities. These participants hold a significant portion of total revenue and contribute to market competitiveness.
Merck & Co.
GlaxoSmithKline plc
Pfizer Inc.
Sanofi
Moderna Inc.
Conclusion:
The outlook for the recombinant vaccines market remains positive, with robust growth expected across multiple segments as global health priorities continue to emphasize vaccine accessibility and coverage. Sustained public health commitments, rising investments in modern vaccine technologies, and increasing adoption of advanced expression platforms underscore anticipated market performance. The recombinant vaccines market analysis indicates that diversified approaches to vaccine development, production, and administration will support long-term expansion and reinforce the role of recombinant vaccines in preventing infectious diseases across populations.
For complete market analysis, please visit the Mordor Intelligence page:
https://www.mordorintelligence.com/industry-reports/recombinant-vaccines-market?utm_source=openpr
Industry related Reports:
Preventive Vaccines Market : The Preventive Vaccines Market segments the industry into By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines, Other Vaccine Types), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps, and Rubella (MMR), COVID-19, Other Disease Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Get more Insights: https://www.mordorintelligence.com/industry-reports/preventive-vaccines-market?utm_source=openpr
Viral Vaccines Market: The Viral Vaccines Market is Segmented by Form (Liquid Vaccines and Lyophilized Vaccines), Type (Live-Attenuated, Inactivated, and More), Approach (Therapeutic and Preventive), Age Group (Pediatric, Adult, and Geriatric), Distribution Channel (Public and Private) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Get more Insights: https://www.mordorintelligence.com/industry-reports/viral-vaccines-market?utm_source=openpr
Vaccines Market:
The Vaccines Market report segments the industry into By Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, mRNA Vaccines, Recombinant Vaccines, Toxoid Vaccines, and more), By Type (Monovalent Vaccines, Multivalent Vaccines), By Disease Indication (DTP, Hepatitis, Herpes Zoster, HPV, Influenza, and more), By Route of Administration (Oral Administration, and more), By End-User, and By Geography.
Get more Insights: https://www.mordorintelligence.com/industry-reports/vaccines-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Vaccines Market Forecast to Reach USD 30.6 Billion by 2030, Driven by Ongoing Technical Enhancements in Vaccine Production and Delivery here
News-ID: 4312168 • Views: …
More Releases from Mordor Intelligence
Surveillance Radar Market Forecast to Reach USD 22.9 Billion by 2031, Driven by …
Report Overview
According to Mordor Intelligence, the Surveillance Radar market is valued at USD 14.04 billion in 2026 and is expected to grow consistently through 2031, supported by defense modernization programs, border monitoring needs, and wider adoption of advanced radar architectures.
Growth Drivers Shaping the Surveillance Radar Market
Shift Toward Software-Defined and Electronically Scanned Radar Systems: The Surveillance Radar Market is undergoing a significant transformation as defense agencies increasingly prioritize adaptable,…
Industrial Hemp Market Size to Reach USD 7.83 Billion by 2031, Driven by Food, T …
The global industrial hemp market is projected to grow from an estimated $ 3.57 billion in 2026 to approximately $ 7.83 billion by 2031, at a CAGR of 17.02 %
industrial hemp market growth is supported by expanding use in food & beverage products, wellness supplements, textiles, construction materials, and regulatory support in key regions like North America and Europe.
Browse Full Report Details Followed by TOC: https://www.mordorintelligence.com/industry-reports/industrial-hemp-market?utm_source=openpr
From plant-based food and beverage…
Security Operation Center as a Service Market to Reach $26.93 Bn by 2031, Driven …
Mordor Intelligence has published a new report on the security operation center as a service market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Security Operation Center as a Service Market Overview
According to Mordor Intelligence, the security operation center as a service market size was valued at USD 14.77 billion in 2026 and is projected to reach USD 26.93 billion by 2031, indicating steady expansion during…
Cheese Market Size Expected to Reach USD 219 Billion by 2031 as Premium Preferen …
Global Cheese Consumption Expands Beyond Traditional Use
The global cheese market size is projected to grow from USD 171.89 billion in 2026 to USD 219.07 billion by 2031, reflecting steady expansion across retail, foodservice, and institutional channels, according to Mordor Intelligence. Cheese is increasingly positioned not only as a staple ingredient but also as a lifestyle-oriented food category supported by premiumization and convenience-led consumption.
Changing dietary habits, urban living, and rising exposure…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
